Can a new pill beat a standard heart drug for a stiff heart condition?
Disease control
Not yet recruiting
This phase 3 trial is testing whether an experimental drug called BHB-1893 works better than the standard beta-blocker metoprolol for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), a condition where the heart muscle thickens and blocks blood flow. The stu…
Phase: PHASE3 • Sponsor: Braveheart Bio, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC